Enlightenment through smart measurements

Open menu

News & Events

OpSens to Present at Lytham Partners Spring 2021 Investor Conference – Presentation at 9:30 a.m. ET on Tuesday, March 30, 2021

22 March 2021

OpSens to Present at Lytham Partners Spring 2021 Investor Conference Presentation at 9:30 a.m. ET on Tuesday, March 30, 2021 Quebec City, Quebec, March 22, 2021 – OpSens Inc. (“OpSens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF),  a medical device cardiology-focused company commercializing a  second-generation fiber optic pressure guidewire to diagnose and treat coronary disease, announced today…

Read more

Article Journal de Québec – OpSens Médical: une technologie prometteuse qui ne tient qu’à un fil

1 March 2021

2021-02-28_JdeQ_OpSens Medical_une technologie prometteuse qui ne tient qua un fil

OpSens: Closing of $28.75 M Bought Deal Public Offering – Including $3.75 M Over-Allotment Option Exercised in Full

25 February 2021

OpSens Announces Closing of $28.75 M Bought Deal Public Offering Including $3.75 M Over-Allotment Option Exercised in Full   THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES Quebec City, Canada, February 25, 2021 – OpSens Inc….

Read more

OpSens Obtains CE Marking for the OptoWire III

18 February 2021

OpSens Obtains CE Marking for the OptoWire III   Quebec City, Quebec, February 18, 2021 – OpSens Inc. (“OpSens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF), a medical device cardiology-focused company commercializing a second-generation fiber optic pressure guidewire to diagnose and treat coronary disease, has announced it has received CE marking for the OptoWire III, the latest…

Read more

OpSens Solutions Fiber Optic Sensing Technology Selected for the International Thermonuclear Experimental Reactor (ITER)

8 February 2021

OpSens Solutions Fiber Optic Sensing Technology Selected for the International Thermonuclear Experimental Reactor (ITER) Quebec City, Quebec, February 8, 2021 – OpSens Inc. (“OpSens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF) today announced that OpSens Solutions Inc. (“OpSens Solutions”), its wholly-owned subsidiary focused on applying the Company’s proprietary and innovative fiber optic measurement solutions to industrial applications,…

Read more

OpSens Announces $25 Million Bought Deal Offering

5 February 2021

OPSENS INC. ANNOUNCES $25 MILLION BOUGHT DEAL OFFERING   THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. Québec City, Canada, February 5, 2021 – OpSens Inc. (“OpSens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF) announced today that it…

Read more

OpSens Announces First Quarter fiscal 2021 financial Results

13 January 2021

OpSens Announces First Quarter fiscal 2021 financial Results Quebec City, Quebec, January 13, 2021 – OpSens Inc. (“OpSens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF), a medical device cardiology-focused company delivering diagnostic and treatment solutions based on its proprietary optical technology, today reported its financial results for the first quarter of fiscal 2021, ended November 30, 2020….

Read more

OpSens to Host First Quarter Fiscal Year 2021 Financial Results Conference Call on Wednesday, January 13, 2021

6 January 2021

OpSens to Host First Quarter Fiscal Year 2021 Financial Results Conference Call on Wednesday, January 13, 2021   Conference call to be conducted at 11:00 am ET Quebec City, Quebec, January 6, 2021 – OpSens Inc. (“OpSens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF), a medical device cardiology-focused company delivering diagnostic and treatment solutions based on its…

Read more

OpSens to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference

24 November 2020

OpSens to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference Quebec City, Quebec, November 24, 2020 – OpSens Inc. (“OpSens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF), a medical device cardiology-focused company delivering diagnostic and treatment solutions based on its proprietary optical technology, is presenting at the Piper Sandler 32nd Annual Virtual Healthcare Conference, and…

Read more

OpSens announces fourth quarter and fiscal year 2020 results

19 November 2020

OpSens Announces Fourth Quarter And Fiscal Year 2020 Financial Results Quebec City, Quebec, November 19, 2020 – OpSens Inc. (“OpSens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF) today reported its results for the fourth quarter and fiscal year 2020 ended August 31, 2020. Financial Highlights Sales of product at $29.5 million in FY 2020 compared to prior…

Read more